BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 15225244)

  • 1. Ceftriaxone causes drug-induced immune thrombocytopenia and hemolytic anemia: characterization of targets on platelets and red blood cells.
    Grossjohann B; Eichler P; Greinacher A; Santoso S; Kroll H
    Transfusion; 2004 Jul; 44(7):1033-40. PubMed ID: 15225244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.
    Arndt PA; Leger RM; Garratty G
    Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone-induced immune thrombocytopenia.
    Liu X; Huang T; Sahud MA
    Platelets; 2006 May; 17(3):143-8. PubMed ID: 16702039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teicoplanin-dependent antibodies: detection and characterization.
    Garner SF; Campbell K; Smith G; Hurd C; Davidson SJ; Treacy M; Burman JF; Kroll H; Ouwehand WH
    Br J Haematol; 2005 Apr; 129(2):279-81. PubMed ID: 15813857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a target glycoprotein in drug-induced thrombocytopenia.
    Kroll H; Sun QH; Santoso S
    Blood; 2000 Aug; 96(4):1409-14. PubMed ID: 10942385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin-induced immune pancytopenia.
    Taleghani BM; Meyer O; Fontana S; Ahrens N; Novak U; Borner MM; Salama A
    Transfusion; 2005 May; 45(5):704-8. PubMed ID: 15847658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequencies of maternal platelet alloantibodies and autoantibodies in suspected fetal/neonatal alloimmune thrombocytopenia, with emphasis on human platelet antigen-15 alloimmunization.
    Mandelbaum M; Koren D; Eichelberger B; Auerbach L; Panzer S
    Vox Sang; 2005 Jul; 89(1):39-43. PubMed ID: 15938738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of antibodies that bind GPIIb/IIIa: antagonist complexes.
    Breth L; Kochie J; Combs A; Wang S; Smallheer J; Billheimer J; Seiffert D; Hollis G; O'Neil K
    J Immunol Methods; 2005 Jun; 301(1-2):11-20. PubMed ID: 15992818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinct subgroups of tirofiban-induced thrombocytopenia exist due to drug dependent antibodies that cause platelet activation and increased ischaemic events.
    Dunkley S; Evans S; Gaudry L; Jepson N
    Platelets; 2005 Dec; 16(8):462-8. PubMed ID: 16287613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia.
    Franchini M; Piccoli PL; Gandini G; Giuffrida A; Bressan F; De Gironcoli M; Aprili G
    Hematology; 2004 Feb; 9(1):65-9. PubMed ID: 14965871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic autoimmune thrombocytopenia: evidence for redistribution of platelet antibodies into the circulation after immunoadsorption treatment.
    Leitner GC; Stiegler G; Horvath M; Hoecker P; Sagaster P; Panzer S
    Am J Hematol; 2003 May; 73(1):44-7. PubMed ID: 12701120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampicin-dependent antibodies bind a similar or identical epitope to glycoprotein IX-specific quinine-dependent antibodies.
    Burgess JK; Lopez JA; Gaudry LE; Chong BH
    Blood; 2000 Mar; 95(6):1988-92. PubMed ID: 10706865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and assessment of enzyme immunoassay for platelet-derived microparticles.
    Osumi K; Ozeki Y; Saito S; Nagamura Y; Ito H; Kimura Y; Ogura H; Nomura S
    Thromb Haemost; 2001 Feb; 85(2):326-30. PubMed ID: 11246556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diclofenac-induced antibodies against red blood cells are heterogeneous and recognize different epitopes.
    Sachs UJ; Santoso S; Röder L; Smart E; Bein G; Kroll H
    Transfusion; 2004 Aug; 44(8):1226-30. PubMed ID: 15265128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
    Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
    Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supernates from stored red blood cells inhibit platelet aggregation.
    Matheu FA; McFaul SJ
    Transfusion; 2010 Jun; 50(6):1196-202. PubMed ID: 20158688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the binding domains on platelet glycoproteins Ib-IX and IIb/IIIa complexes for the quinine/quinidine-dependent antibodies.
    Chong BH; Du XP; Berndt MC; Horn S; Chesterman CN
    Blood; 1991 May; 77(10):2190-9. PubMed ID: 1709374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinine-dependent antibodies bind a restricted set of epitopes on the glycoprotein Ib-IX complex: characterization of the epitopes.
    Burgess JK; Lopez JA; Berndt MC; Dawes I; Chesterman CN; Chong BH
    Blood; 1998 Oct; 92(7):2366-73. PubMed ID: 9746776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmune thrombocytopenia in chronic liver disease].
    Panasiuk A; Zak J
    Pol Merkur Lekarski; 2001 Dec; 11(66):487-90. PubMed ID: 11899844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms.
    Curtis BR
    Immunohematology; 2014; 30(2):55-65. PubMed ID: 25247620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.